SCOTTSDALE, AZ -- (Marketwire) -- 06/30/11 -- Rural/Metro Corporation (NASDAQ: RURL), a leading national provider of ambulance and private fire protection services, today announced the completion...
Leading pelvic-health devices maker American Medical Systems (AMMD) recently initiated a large-scale global registry of penile prosthetic outcomes. The new registry, dubbed PROPPER (Prospective...
American Medical Systems Holdings, Inc. (“AMS” or the “Company”) (NASDAQ: AMMD) announced that, pursuant to the terms of the indenture (the “2041 Indenture”) governing its 4.00...
American Medical Systems Announces Large-Scale, Physician-Led Registry of Penile Implants Multi-Year, AMS-Sponsored PROPPER Registry to Better Understand Real-World Penile Prosthetic Outcomes...
Standard & Poor's Announces Changes to U.S. Index PR Newswire NEW YORK, June 9, 2011 NEW YORK, June 9, 2011 /PRNewswire/ -- OYO Geospace Corp. (NASD: OYOG) will replace LaBranche & Co Inc. (NYSE:...
American Medical Systems Holdings, Inc. (“AMS” or the “Company”) (NASDAQ: AMMD) announced that it had signed a memorandum of understanding today to settle the previously...
American Medical Systems Holdings, Inc. (“AMS” or the “Company”) (NASDAQ: AMMD) announced that, pursuant to the terms of the indenture (the “2036 Indenture”) governing its 3 ¼...
Recently, the US Food and Drug Administration (FDA) helped boost Endo Pharmaceuticals’ (ENDP) generic portfolio by approving dexamethasone elixir and Orsythia tablets. Dexamethasone...
Leading pelvic-health devices provider American Medical Systems (AMMD) recently signed a research grant contract for six sites to analyze safety, anatomical and functional results of two...
We are maintaining our Neutral stance on Endo Pharmaceuticals (ENDP) with a target price of $44.00. Headquartered in Chadds Ford, Pennsylvania and founded in 1997, Endo Pharma is a specialty...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.